Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
2008 1
2010 2
2011 2
2012 1
2015 1
2016 2
2017 2
2019 2
2020 2
2022 2
2023 2
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Ethnicity, recurrence score distribution, and clinical outcomes in ER + HER2-negative breast cancer patients in Israel: A registry analysis.
Bar-Sela G, Samih Y, Yerushalmi R, Leviov M, Efrat Ben-Baruch N, Kuchuk I, Tokar M, Peretz-Yablonski T, Sonnenblick A, Soussan-Gutman L, Bareket-Samish A, Fried G, Paluch-Shimon S, Kaufman B, Hammerman A, Liebermann N, Stemmer SM. Bar-Sela G, et al. Among authors: liebermann n. Breast J. 2020 Oct;26(10):2096-2098. doi: 10.1111/tbj.13870. Epub 2020 May 18. Breast J. 2020. PMID: 32419268 No abstract available.
Sidedness Matters: Surrogate Biomarkers Prognosticate Colorectal Cancer upon Anatomic Location.
Ben-Aharon I, Goshen-Lago T, Sternschuss M, Morgenstern S, Geva R, Beny A, Dror Y, Steiner M, Hubert A, Idelevich E, Shulman K, Mishaeli M, Man S, Liebermann N, Soussan-Gutman L, Brenner B. Ben-Aharon I, et al. Among authors: liebermann n. Oncologist. 2019 Aug;24(8):e696-e701. doi: 10.1634/theoncologist.2018-0351. Epub 2019 Feb 12. Oncologist. 2019. PMID: 30755502 Free PMC article.
NECI: N-Electron Configuration Interaction with an emphasis on state-of-the-art stochastic methods.
Guther K, Anderson RJ, Blunt NS, Bogdanov NA, Cleland D, Dattani N, Dobrautz W, Ghanem K, Jeszenszki P, Liebermann N, Manni GL, Lozovoi AY, Luo H, Ma D, Merz F, Overy C, Rampp M, Samanta PK, Schwarz LR, Shepherd JJ, Smart SD, Vitale E, Weser O, Booth GH, Alavi A. Guther K, et al. Among authors: liebermann n. J Chem Phys. 2020 Jul 21;153(3):034107. doi: 10.1063/5.0005754. J Chem Phys. 2020. PMID: 32716189
Oncotype-DX recurrence score distribution in breast cancer patients with BRCA1/2 mutations.
Lewin R, Sulkes A, Shochat T, Tsoref D, Rizel S, Liebermann N, Hendler D, Neiman V, Ben-Aharon I, Friedman E, Paluch-Shimon S, Margel D, Kedar I, Yerushalmi R. Lewin R, et al. Among authors: liebermann n. Breast Cancer Res Treat. 2016 Jun;157(3):511-6. doi: 10.1007/s10549-016-3836-6. Epub 2016 May 25. Breast Cancer Res Treat. 2016. PMID: 27225387
Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registry.
Stemmer SM, Steiner M, Rizel S, Geffen DB, Nisenbaum B, Peretz T, Soussan-Gutman L, Bareket-Samish A, Isaacs K, Rosengarten O, Fried G, McCullough D, Svedman C, Shak S, Liebermann N, Ben-Baruch N. Stemmer SM, et al. Among authors: liebermann n. NPJ Breast Cancer. 2017 Sep 8;3:32. doi: 10.1038/s41523-017-0033-7. eCollection 2017. NPJ Breast Cancer. 2017. PMID: 28900632 Free PMC article.
Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy.
Stemmer SM, Steiner M, Rizel S, Ben-Baruch N, Uziely B, Jakubowski DM, Baron J, Shak S, Soussan-Gutman L, Bareket-Samish A, Fried G, Rosengarten O, Itay A, Nisenbaum B, Katz D, Leviov M, Tokar M, Liebermann N, Geffen DB. Stemmer SM, et al. Among authors: liebermann n. NPJ Breast Cancer. 2019 Nov 8;5:41. doi: 10.1038/s41523-019-0137-3. eCollection 2019. NPJ Breast Cancer. 2019. PMID: 31728408 Free PMC article.
20 results